09966.HK
Alphamab Oncology
HKSE · Healthcare · Biotechnology · CN
HKD 7.75
+1.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 59.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.81x
- Price / sales
- 12.38x
- Price / cash flow
- -52.25x
Enterprise value
- Enterprise value
- HKD 6.1B
- EV / sales
- 10.12x
- EV / EBITDA
- -39.82x
- EV / EBIT
- -26.61x
- Market cap
- HKD 7.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026